What does an elevated AST indicate?

Elevated AST most commonly reflects hepatocellular injury from viral, autoimmune, metabolic, or drug-induced liver disease. It also rises with myocardial infarction, rhabdomyolysis, haemolysis, and strenuous exercise, so correlation with ALT, CK, troponin, and haemolysis indices is essential.

Why is the AST:ALT ratio clinically useful?

The ratio helps distinguish causes of liver injury. An AST:ALT ratio below one is typical of steatotic liver disease and chronic viral hepatitis; above two suggests alcohol-related liver disease or cirrhosis. A very high AST with a ratio near one often signals acute ischaemic or toxic hepatitis.

Can AST be normal in someone with liver disease?

Yes. Cirrhosis, chronic hepatitis, and infiltrative liver disease can present with normal or minimally elevated AST, so a normal result does not exclude significant liver disease and should be read alongside the rest of the liver panel.

Is fasting required for an AST test?

No. AST does not require fasting, though it is often drawn as part of a metabolic panel that may specify fasting for glucose and lipid analytes.

Why should patients avoid heavy exercise before the test?

AST is abundant in skeletal and cardiac muscle, so strenuous exercise, intramuscular injections, or muscle injury can markedly elevate it. Resting before the draw reduces the chance of a muscle-related elevation.

Macro-AST is a rare benign phenomenon in which AST binds to immunoglobulin or lipoprotein, forming a complex that persists in the circulation. It causes persistent asymptomatic elevation without tissue injury and should be suspected when AST is disproportionately high, stable over time, and the patient is well.

Does the result differ between laboratories?

Yes. Reference limits for AST differ by laboratory, sex, and assay methodology. Serial results are best compared within the same performing laboratory, and the routing lab is noted for this reason.

How long do AST results take?

Results are typically available within 2–3 business days from specimen receipt at Access Medical Laboratories.

BML-GAS-060gastrointestinalUSA

Aspartate Aminotransferase (AST) Test

The AST test measures serum aspartate aminotransferase, an enzyme in liver, heart, and muscle released during cellular injury. It is a sensitive but non-specific marker of hepatocellular damage, interpreted with ALT to calculate the AST:ALT ratio — below one suggests steatotic or viral liver disease, above two suggests alcohol-related injury — and correlated with CK and troponin when non-hepatic…

Biomarkers

Blood (serum)

Sample

2–3 business days

Turnaround

Fasting

What is the AST test?

The Aspartate Aminotransferase (AST) Test measures the serum activity of an enzyme released from damaged cells in liver, heart, muscle, and other tissues. Although it lacks the tissue specificity of troponin or ALT, AST remains a cornerstone of the liver chemistry panel and is ordered both to detect hepatocellular injury and to refine its cause when interpreted with ALT, alkaline phosphatase, and bilirubin. Practitioners rely on the AST:ALT ratio as much as the absolute value: a low ratio favours metabolic or viral liver disease, a high ratio suggests alcohol-related injury or advanced fibrosis, and a very high AST with a ratio near one can signal acute ischaemic or toxic hepatitis. Beyond the liver, AST elevations accompany myocardial infarction, rhabdomyolysis, and haemolysis, so correlation with creatine kinase, troponin, and haemolysis indices is often needed. The test is ordered to screen, to monitor known liver or muscle disease, and to follow trends rather than to diagnose from a single result.

What does the AST test measure?

AST(Aspartate Aminotransferase)

Range: Approximately 8–48 U/L, sex- and assay-specific.Optimal: Some hepatology references advocate for lower healthy thresholds (approximately ≤30–35 U/L in men and ≤25–30 U/L in women) than traditional laboratory upper limits, mirroring the evidence base for ALT.U/L / µkat/L

Aspartate aminotransferase is a pyridoxal-5'-phosphate-dependent enzyme present in both cytosolic and mitochondrial compartments of cells. It catalyses the reversible transfer of an amino group from aspartate to alpha-ketoglutarate, forming oxaloacetate and glutamate, a reaction central to amino-acid catabolism and the malate-aspartate shuttle. AST is abundant in hepatocytes, cardiac myocytes, skeletal muscle, kidney, brain, and red blood cells, so elevated serum activity is less tissue-specific than ALT. When cells are damaged the cytosolic isoform is released early; severe or prolonged injury releases the mitochondrial isoform, which persists longer in the circulation.

AST is a sensitive but non-specific marker of cellular injury. In liver disease it is interpreted alongside ALT: the AST:ALT ratio distinguishes patterns — values below one suggest hepatic steatosis or chronic viral hepatitis, while ratios above two point to alcohol-related liver injury or cirrhosis. In acute myocardial infarction AST rises within hours and peaks at one to two days, though troponin has supplanted it as the cardiac marker of choice. Practitioners use AST to screen for liver injury, to classify liver-injury patterns in conjunction with other liver enzymes, and to assess the severity of hepatocellular damage when mitochondrial AST is released.

Why is the AST test ordered?

Investigation of suspected hepatocellular injury in patients with jaundice, right upper quadrant pain, fatigue, or incidental abnormal liver biochemistry
Differentiation of hepatocellular from cholestatic liver injury when paired with alkaline phosphatase and bilirubin, and determination of the AST:ALT ratio to suggest aetiology
Screening and monitoring of chronic liver disease including metabolic dysfunction-associated steatotic liver disease, viral hepatitis, autoimmune hepatitis, and cirrhosis
Baseline and serial monitoring of patients on potentially hepatotoxic medications such as statins, methotrexate, isoniazid, and antiretroviral agents
Assessment of possible alcohol-related liver injury, where an AST:ALT ratio above two and elevated GGT provide supporting evidence
Evaluation of suspected myocardial infarction in the absence of troponin availability, or of rhabdomyolysis when correlated with creatine kinase
Work-up of persistently elevated transaminases found on routine metabolic or wellness panels

Sample collection and turnaround

Sample type

Blood (serum)

Fasting required

Collection method

Venipuncture at patient service centre

Turnaround

2–3 business days

Collection notes

Phlebotomy required at the Access Medical Laboratories draw site; no special preparation. Avoid strenuous exercise and intramuscular injections shortly before the draw. Reject grossly haemolysed specimens, which spuriously elevate AST.

Specimen requirements

Minimum 0.5 mL serum (gel separator acceptable). Separate from cells within two hours of collection; AST is stable refrigerated for several days. Note the performing laboratory to ensure serial comparability, as reference limits vary.

What can affect AST results?

elevatesHaemolysis of the specimen

Red blood cells contain AST, so in vitro haemolysis releases enzyme into serum and spuriously raises the result; grossly haemolysed samples should be rejected.

elevatesStrenuous exercise and skeletal muscle injury

AST is abundant in skeletal and cardiac muscle; vigorous exercise, trauma, intramuscular injections, or rhabdomyolysis can markedly elevate AST, necessitating correlation with creatine kinase.

reducesPyridoxine (vitamin B6) deficiency

AST activity depends on pyridoxal-5'-phosphate; B6 deficiency, seen in malnutrition or chronic alcohol use, lowers measured AST and can mask true injury.

elevatesObesity and hepatic steatosis

Steatotic liver disease causes chronic mild elevation of aminotransferases, typically with AST lower than ALT (ratio <1), prompting metabolic evaluation.

elevatesMedications and herbal supplements

Hepatotoxic drugs, including paracetamol overdose, isoniazid, valproate, and certain herbal or bodybuilding supplements, cause dose-dependent or idiosyncratic hepatocellular injury.

elevatesMacro-AST

Rare complexes of AST bound to immunoglobulin or lipoprotein persist in the circulation and cause persistent elevation without tissue injury; macro-AST should be suspected when AST is disproportionately elevated, asymptomatic, and stable over time.

What do AST results mean?

Elevated

Hepatocellular injury is the most common cause — viral, autoimmune, or drug-induced hepatitis, steatotic liver disease, alcohol-related liver injury, ischaemic hepatitis, haemochromatosis, or Wilson disease. An AST:ALT ratio below one suggests steatotic or chronic viral liver disease; above two suggests alcohol-related injury or cirrhosis. Very high values (>10× upper limit) typically reflect acute viral, toxic, or ischaemic injury. Non-hepatic causes include myocardial infarction (though troponin is preferred), rhabdomyolysis (AST and CK both elevated), haemolysis, and macro-AST.

Normal

A normal AST does not exclude significant liver disease — cirrhosis, chronic hepatitis, and infiltrative liver disease can present with normal or minimally elevated aminotransferases. Interpret AST within the full liver panel and clinical context rather than in isolation.

Reduced

Low AST is not clinically significant in most cases but may occur with severe pyridoxine deficiency, which can mask underlying hepatocellular injury, and has been associated with uraemia.

Note: AST is less liver-specific than ALT, so correlation with creatine kinase, troponin, and haemolysis indices is essential when non-hepatic sources are suspected. The AST:ALT ratio and the pattern with alkaline phosphatase and bilirubin are more informative than the absolute AST value. Reference limits differ among laboratories and assays; serial measurements should be compared within the same laboratory where feasible.

Frequently asked questions

Both are aminotransferases that rise in liver injury, but AST is also abundant in heart and skeletal muscle while ALT is more liver-specific. The AST:ALT ratio helps identify the cause — below one suggests steatotic or chronic viral liver disease, above two suggests alcohol-related injury or cirrhosis.

How to access the AST test

The AST reference page is free and open to all practitioners. Create a free practitioner account to see pricing, save tests to your list, and generate requisition forms. Verification takes 1–2 business days.

Create Free Account

About this page

Published: October 7, 2026

Last reviewed: October 7, 2026

References:

Kwo PY, et al. ACG clinical guideline: evaluation of abnormal liver chemistries. Am J Gastroenterol. (2017)
Crabb DW, et al. Diagnosis and treatment of alcohol-associated liver diseases: AASLD practice guidance. Hepatology. (2020)
Prati D, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. (2002)
EASL clinical practice guidelines: drug-induced liver injury. J Hepatol. (2019)
Thygesen K, et al. Fourth universal definition of myocardial infarction. Circulation. (2018)

This content is for licensed healthcare practitioners only and does not constitute medical advice. Clinical decisions should be based on the full clinical picture and not on any single test result.

Related tests

gastrointestinal

ALT

The ALT test measures serum alanine aminotransferase, a cytosolic hepatocyte enzyme released during liver cell injury and the most liver-specific routine aminotransferase. It is the first-line marker of hepatocellular damage, interpreted with AST, ALP, GGT, and bilirubin and the AST:ALT ratio to classify liver injury, screen for steatotic liver disease, and monitor hepatotoxic therapy.

BML-GAS-052View reference →

metabolic diabetes

CMP

The Comprehensive Metabolic Panel is a 14-analyte serum chemistry panel simultaneously evaluating renal function (creatinine, BUN, eGFR), hepatic function (ALT, AST, total bilirubin, albumin, total protein), metabolic status (glucose, calcium), and electrolyte-acid-base homeostasis (sodium, potassium, chloride, bicarbonate) from a single fasting serum specimen.

BML-MET-003View reference →